Sercan Aksoy

Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia

Z. Arık, G. Güner, N. Kertmen, 2023, Current oncology.

Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-Analysis

D. Guven, TK Sahin, Sercan Aksoy, 2024, Cancers.

The impact of human epidermal growth factor receptor-2 (low) status on the efficacy of first line cyclin-dependent kinase 4/6 inhibitors in advanced breast cancer

O. Yazıcı, Y. Urun, B. Oksuzoglu, 2024, Medicine.

Impact of opioid analgesics on survival in cancer patients receiving immune checkpoint inhibitors

S. Kılıçkap, D. Guven, Ece Karaca, 2024, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.

Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer

S. Mehrotra, E. Banoglu, O. Sahin, 2023, bioRxiv.

Reliability and validity of the 6-minute pegboard and ring test for functional exercise capacity in patients with breast cancer.

M. Sağlam, N. Vardar Yağlı, E. Calik-Kutukcu, 2024, Physiotherapy theory and practice.

Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study

B. Cirauqui, R. Swaby, J. Ge, 2024, BMC cancer.

The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study.

A. Erdoğan, S. Kılıçkap, B. Çakar, 2024, International journal of clinical oncology.

Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving Chemotherapy

Y. Baytar, O. Aktepe, H. Taban, 2024, Cancers.

Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab

S. Kılıçkap, D. Guven, H. Yıldırım, 2023, Journal of immunotherapy and precision oncology.